Conserved sites on the influenza H1 and H3 hemagglutinin recognized by human antibodies
Science Advances · 25.04.2025 · 11 (17)
DOI: 10.1126/sciadv.adu9140 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 25.04.2025. Verfasst von Daniel P Maurer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA. Hauptthemen laut MEDLINE: Hemagglutinin Glycoproteins, Influenza Virus, Antibodies, Viral, Influenza A Virus, H1N1 Subtype. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCI NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Monoclonal antibodies (mAbs) targeting the influenza hemagglutinin (HA) can be used as prophylactics or templates for next-generation vaccines. Here, we isolated broad, subtype-neutralizing mAbs from human B cells recognizing the H1 or H3 HA “head” and a mAb engaging the conserved stem. The H1 mAbs bind the lateral patch epitope on HAs from 1933 to 2021 and a prepandemic swine H1N1 virus. We improved neutralization potency using directed evolution toward a contemporary H1 HA. Deep mutational scanning of four antigenically distinct H1N1 viruses identified potential viral escape pathways. For the H3 mAbs, we used cryo–electron microscopy to define their epitopes: One mAb binds the side of the HA head, accommodating the N133 glycan and a pocket underneath the receptor binding site; the other mAb recognizes an HA stem epitope that partially overlaps with previously characterized mAbs but with distinct antibody variable genes. Collectively, these mAbs identify conserved sites recognized by broadly-reactive mAbs that may be elicited by next-generation vaccines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA.
- Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
- Adimab LLC, Lebanon, NH 03766, USA.
- Invivyd Inc., Waltham, MA 02451, USA.
- Department of Microbiology, Harvard Medical School, Boston, MA 02115, USA.
ORCID-Profile: Daniel P Maurer, Mya Vu, Haley L Dugan, Paul Khalife, Laura M Walker, Goran Bajic, Aaron G Schmidt
Förderung
- NIAID NIH HHS
- NCI NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Maurer, D. P., Vu, M., Ferreira Ramos, A. S., Dugan, H. L., Khalife, P., Geoghegan, J. C., Walker, L. M., Bajic, G., & Schmidt, A. G. (2025). Conserved sites on the influenza H1 and H3 hemagglutinin recognized by human antibodies. Science Advances, 11(17). https://doi.org/10.1126/sciadv.adu9140
Vancouver
Maurer DP, Vu M, Ferreira Ramos AS, Dugan HL, Khalife P, Geoghegan JC, et al. Conserved sites on the influenza H1 and H3 hemagglutinin recognized by human antibodies. Science Advances. 2025;11(17). doi:10.1126/sciadv.adu9140
BibTeX
@article{Maurer2025,
author = {Maurer, Daniel P and Vu, Mya and Ferreira Ramos, Ana Sofia and Dugan, Haley L and Khalife, Paul and Geoghegan, James C and Walker, Laura M and Bajic, Goran and Schmidt, Aaron G},
title = {Conserved sites on the influenza H1 and H3 hemagglutinin recognized by human antibodies},
journal = {Science Advances},
year = {2025},
volume = {11},
number = {17},
doi = {10.1126/sciadv.adu9140}
}
EUVIMED